• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BioMarin Pharmaceutical Inc

+ Add to Watchlist


43.878 EUR 1.938 4.62%

As of 09:55:27 ET on 04/17/2014.

Snapshot for BioMarin Pharmaceutical Inc (BM8)

Open: 43.405 Day's Range: 43.405 - 44.475 Volume: 140
Previous Close: 41.940 52wk Range: 40.895 - 63.510 1-Yr Rtn: -9.82%

Stock Chart for BM8

No chart data available.
  • BM8:GR 43.878
  • 1D
  • 1M
  • 1Y
Interactive BM8 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BM8

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.5280
Est. PEG Ratio -
Market Cap (M EUR) 6,360.72
Shares Outstanding (M) 144.96
30 Day Average Volume 179
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BM8

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BM8

BioMarin Pharmaceutical Inc. develops and commercializes therapeutic enzyme products. The Company has applied its proprietary enzyme technology to develop products for lysosomal storage diseases and for the treatment of serious burns. BioMarin's subsidiary provides analytical and diagnostic products and services in the area of carbohydrate biology.

Jean-Jacques BienaimeChief Executive OfficerDaniel K Spiegelman "Dan"Exec VP/CFO
Henry J FuchsExec VP/Chief Medical OfficerRobert A BaffiExec VP:Technical Operations
More Company Profile & Key Executives for BM8

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil